Los Angeles Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Los Angeles Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,469	Closed	-$212K	–	1434
2022 Q2	$212K	Buy	+13,469	New	+$206K	﹤0.01%	1250
2021 Q2	–	Sell	-278,769	Closed	-$3.33M	–	1723
2021 Q1	$3.33M	Sell	278,769 -73,036	-21%	-$828K	0.02%	491
2020 Q4	$3.2M	Sell	351,805 -165,291	-32%	-$1.28M	0.01%	509
2020 Q3	$3.15M	Buy	517,096 +90,006	+21%	+$687K	0.01%	440
2020 Q2	$3.79M	Buy	427,090 +226,933	+113%	+$1.96M	0.02%	455
2020 Q1	$1.45M	Buy	200,157 +145,069	+263%	+$1.08M	0.01%	622
2019 Q4	$486K	Sell	55,088 -11,055	-17%	-$82.7K	﹤0.01%	1025
2019 Q3	$403K	Buy	+66,143	New	+$372K	﹤0.01%	1052

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Los Angeles Capital Management's NPTN Position: Q3 2022 in Review

Los Angeles Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 13,469 shares — an estimated $212K sold.

Los Angeles Capital Management first reported a position in NPTN in Q3 2019 and held it in 8 quarters. The position peaked at $3.79M in Q2 2020. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Los Angeles Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Los Angeles Capital Management sold 13,469 NEOPHOTONICS CORP shares in Q3 2022, an estimated $212K.
Los Angeles Capital Management first reported a position in NEOPHOTONICS CORP in Q3 2019 and held it in 8 quarters.
Los Angeles Capital Management's NEOPHOTONICS CORP position peaked at $3.79M in Q2 2020.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.